In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abingdon Health Ltd.

http://www.abingdon-health.com

Latest From Abingdon Health Ltd.

Pandemic Perspectives: A Lasting Impact On Medtech, But Not Dealmaking

The COVID-19 pandemic has fundamentally changed health care and the life sciences, KPMG analyst Kristin Pothier concludes in a new report on the medtech investment outlook.

Commercial Deals

Trial Shows Lateral Flow Antibody Testing Could Be Used To Assess COVID-19 Vaccine Efficacy

Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy.

Diagnostics Clinical Trials

Test Supply Problems Hit Roche In UK, Company Prioritizes COVID-19 Products

Move to new distribution center blamed for "very significant" drop in processing capacity for some IVD products.

United Kingdom Companies

UK Consortium Given Go-Ahead For Rapid SARS-CoV-2 Antibody Test In Europe

UK-Rapid Test Consortium claims the CE marked, professional-use test is 99.4% accurate and plans to produce 500,000 tests a month from October and one million a month starting in 2021.

Europe Coronavirus COVID-19
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Contract Manufacturing Organization
UsernamePublicRestriction

Register